This milestone marks a significant step forward in the clinical development of VX-01, potentially the first oral treatment for this condition, designed to target the inflammatory mechanisms ...

LONDON, April 11, 2025 (GLOBE NEWSWIRE) -- Vantage Biosciences, a clinical stage biotechnology company advancing innovative therapies for diabetic eye diseases, today announced that the first ...

This milestone marks a significant step forward in the clinical development of VX-01, potentially the first oral treatment for this condition, designed to target the inflammatory mechanisms underlying ...

The 1996 VS HSV GTS-R is one of the most unique Aussie-built cars to come out of the 90s. You either loved it, or hated it, and nothing in between. The car featured bright “Yellah” yellow ...

It saddens us to say this but reviewing the 2016 HSV GTS GEN-F2 will probably be the last time we test an Australian V8 sedan with over 400kW. Let’s go over it one last time to help mourn the ...

Vantage Biosciences has begun a phase 2 trial for VX-01, targeting moderate to severe NPDR without CI-DME. The study is double masked, randomized, placebo controlled, and involves a 52-week treatment ...